US vape companies braced for the worst after rule change on synthetic nicotine

The US vaping industry expects the decision to treat synthetic nicotine products the same as tobacco products to devastate parts of the industry that have come to rely on it, with some businesses forced to close and others having to hope for enforcement discretion.

Synthetic nicotine will be treated the same as tobacco-derived nicotine by the US Food and Drug Administration (FDA) after president Joe Biden signed a sweeping $1.5tn omnibus spending bill.

The bill’s passing has caused a lot of concern among small businesses, which will no longer be able to compete, being less diversified and less able to leverage economies of scale or access capital markets.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us